Cramps and muscular pain: Prevention with Pycnogenol® in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy

Angiology

Volumn 57, Issue 3, 2006, Pages 331-339

  Vinciguerra, G ^a   Belcaro, G ^b   Cesarone, M R ^b   Rohdewald, P ^b   Stuard, S ^b   Ricci, A ^b   Di Renzo, A ^b   Hosoi, M ^b   Dugall, M ^b   Ledda, A ^b   Cacchio, M ^b   Acerbi, G ^b   Fano, F ^b  

^a Fac Motory Sciences L'Aquila   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PYCNOGENOL; ANALGESIC AGENT; FLAVONOID; PYCNOGENOLS;

ADULT; AGED; ARTICLE; ATHLETE; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; DRUG EFFICACY; EXERCISE; FEMALE; FOLLOW UP; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; MYALGIA; PATIENT MOBILITY; PROSPECTIVE STUDY; STANDING; VEIN DISEASE; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; LEG; MIDDLE AGED; PAIN; PAIN ASSESSMENT; SPORT; VEIN INSUFFICIENCY;

ADULT; ANALGESICS; DIABETIC ANGIOPATHIES; EXERCISE; FEMALE; FLAVONOIDS; HUMANS; INTERMITTENT CLAUDICATION; LEG; MALE; MIDDLE AGED; MUSCLE CRAMP; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SPORTS; VENOUS INSUFFICIENCY;

EID: 33745546228     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970605700309     Document Type: Article

References (34)

1. Shaker HK, Mackler L, Huber TE: Clinical inquiries. What is the diagnostic approach to a patient with leg cramps? J Fam Pract 54:817-818, 2005.
2. Miller TM, Layzer RB: Muscle cramps. Muscle Nerve 32:431-442, 2005.
3. Robertson N, Hale W, Mackler L, et al: Clinical inquiries. Does quinine reduce leg cramps for young athletes? J Fam Pract 54:76-78, 2005.
4. Frusso R, Zarate M, Augustovski F, et al: Magnesium for the treatment of nocturnal leg cramps: A crossover randomized trial. J Fam Pract 48:868-871, 1999.
5. 3, pH and magnesium in human venous and capillary blood. Life Sci Jan 17, 2006.
6. McCully KK, Malucelli E, Iotti S: Increase of free Mg2+ in the skeletal muscle of chronic fatigue syndrome patients. Dyn Med 5:1, 2006.
7. Kumeda Y, Inaba M: Metabolic syndrome and magnesium. Clin Calcium 15:97-104, 2005.
8. Nishimuta M, Kodama N, Morikuni E, et al: Positive correlation between dietary intake of sodium and balances of calcium and magnesium in young Japanese adults - low sodium intake is a risk factor for loss of calcium and magnesium. J Nutr Sci Vitaminol 51:265-270, 2005.
9. Muller-Felber W: Muscular pain in viral infections. MMW Fortschr Med 147:45-46, 2005.
10. Alonso-Navarro H, Jimenez-Jimenez FJ: Myalgia and cramps associated with zolmitriptan. Clin Neuropharmacol 28:241-242, 2005.
11. Troseid M, Henriksen OA, Lindal S: Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family. APMIS 113:635-637, 2005.
12. Martino S, Disch D, Dowsett SA, et al: Safety assessment of raloxifene over eight years in a clinical setting. Curr Med Res Opin 21:1441-1452, 2005.
13. Kuwabara S, Misawa S: Axonal ionic pathophysiology in human peripheral neuropathy and motor neuron disease. Curr Neurovasc Res 1:373-379, 2004.
14. Rohdewald P: A review of the French maritime pine bark extract (Pycnogenol), an herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40:158-168, 2002.
15. Williamson G, Manach C: Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81(suppl 1):243S-255S, 2005.
16. Nelson AB, Lau BH, Ide N, et al: Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage. Drug Dev Ind Pharm 24:139-144, 1998.
17. Belcaro G, Cesarone MR, Rohdewald P, et al: Prevention of venous thrombosis and thrombophlebitis in long-haul flights with Pycnogenol. Clin Appl Thromb Hemost 10:373-377, 2004.
18. Sivonova M, Waczulikova I, Kilanczyk E, et al: The effect of Pycnogenol on the erythrocyte membrane fluidity. Gen Physiol Biophys 23:39-51, 2004.
19. Grimm T, Schäfer A, Högger P: Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (Pycnogenol). Free Radic Biol Med 36:811-822, 2004.
20. Belcaro G, Nicolaides AN: Noninvasive Investigations in Vascular Disease. London: Imperial College Press, 2000.
21. Morton DP, Richards D, Callister R: Epidemiology of exercise-related transient abdominal pain at the Sydney City to Surf community run. J Sci Med Sport 8:152-162, 2005.
22. Isackson PJ, Bujnicki H, Harding CO, et al: Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene. Mol Genet Metab 86:250-256, 2005.
23. Sulzer NU, Schwellnus MP, Noakes TD: Serum electrolytes in Ironman triathletes with exercise-associated muscle cramping. Med Sci Sports Exerc 37:1081-1085, 2005.
24. Jung AP, Bishop PA, Al-Nawwas A, et al: Influence of hydration and electrolyte supplementation on incidence and time to onset of exercise-associated muscle cramps. J Athl Train 40:71-75, 2005.
25. Klingler W, Heffron JJ, Jurkat-Rott K, et al: 3,4- Methylenedioxymethamphetamine (ecstasy) activates skeletal muscle nicotinic acetylcholine receptors. J Pharmacol Exp Ther 314:1267-1273, 2005.
26. Cesarone MR, Belcaro G, Nicolaides AN, et al: Prevention of venous thrombosis in long-haul flights with Flite Tabs: The LONFLIT-FLITE randomized, controlled trial. Angiology 54:531-539, 2003.
27. Devaraj S, Vega-Lopez S, Kaul N, et al: Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids 37:931-934, 2002.
28. Silliman K, Parry J, Kirk LL, et al: Pycnogenol does not impact the antioxidant or vitamin C status of healthy young adults. J Am Diet Assoc 103:67-72, 2003.
29. Cho KJ, Yun CH, Packer L, et al: Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines. Ann NY Acad Sci 928:141-156, 2001.
30. Bito T, Roy S, Sen CK, et al: Pine bark extract Pycnogenol downregulates IFN-gamma-induced adhesion of T cells to human keratinocytes by inhibiting inducible ICAM-1 expression. Free Radic Biol Med 28:219-227, 2000.
31. Rihn B, Saliou C, Bottin MC, et al: From ancient remedies to modern therapeutics: Pine bark uses in skin disorders revisited. Phytother Res 15:76-78, 2001.
32. 1 short-term study. A randomised 40-week study. Evaluation of efficacy and costs. Minerva Cardioangiol 50:683-690, 2002.
33. 1 treatment of severe intermittent claudication (short-term versus long-term, associated with exercise) - efficacy and costs in a 20-week, randomized trial. Angiology 5:S15-S26, 2000.
34. Vissing J, Quistorff B, Haller RG: Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency. Arch Neurol 62:1440-1443, 2005.